Readystate Asset Management LP Biomarin Pharmaceutical Inc Transaction History
Readystate Asset Management LP
- $3.08 Trillion
- Q2 2024
A detailed history of Readystate Asset Management LP transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Readystate Asset Management LP holds 10,911 shares of BMRN stock, worth $718,925. This represents 0.03% of its overall portfolio holdings.
Number of Shares
10,911
Previous 12,726
14.26%
Holding current value
$718,925
Previous $1.11 Billion
19.18%
% of portfolio
0.03%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding BMRN
# of Institutions
631Shares Held
184MCall Options Held
1.63MPut Options Held
1.2M-
Black Rock Inc. New York, NY22.7MShares$1.5 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.25 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA18.8MShares$1.24 Billion1.14% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$918 Million0.72% of portfolio
-
Capital Research Global Investors Los Angeles, CA9.69MShares$639 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.2B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...